Exercise Program for Prostate Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a 16-week supervised exercise program can help men with prostate cancer who feel frail due to their treatment. The focus is on improving strength and reducing disease progression for those undergoing androgen deprivation therapy, a common prostate cancer treatment. Participants will either join a supervised exercise group (Supervised Circuit Training) or continue their normal activities to compare results. Ideal candidates are those with metastatic prostate cancer who have experienced frailty and do not currently engage in regular exercise. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance the quality of life for prostate cancer patients.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you must be on androgen deprivation therapy and cannot be receiving chemotherapy or treatment for other active cancers, except for basal cell carcinoma.
What prior data suggests that this exercise program is safe for prostate cancer patients?
Research shows that supervised exercise programs are generally safe and well-tolerated by participants. Studies have demonstrated that these programs can enhance the quality of life for people with prostate cancer. For example, one study found that a supervised exercise program helped reduce side effects from androgen deprivation therapy (ADT), a common prostate cancer treatment.
Another study compared exercises done at home with those done in supervised groups and found both methods effective and manageable for participants. This indicates that supervised exercises, like those in this trial, have been safely used in similar situations.
Overall, evidence suggests that supervised exercise is a safe option for most people, with no major negative effects reported in the studies reviewed.12345Why are researchers excited about this trial?
Researchers are excited about the supervised circuit training program for prostate cancer because it offers a non-invasive approach that could complement existing treatments like surgery, radiation, or hormone therapy. Unlike traditional treatments that directly target cancer cells, this exercise regimen focuses on improving overall physical health, which may help patients better tolerate cancer treatments and improve their quality of life. The program's unique feature is its structured and supervised environment, ensuring participants engage safely and effectively, potentially leading to improved outcomes and reduced treatment side effects.
What evidence suggests that this exercise program is effective for prostate cancer?
Research has shown that supervised exercise can greatly improve the quality of life for people with prostate cancer. In this trial, participants in the Exercise Group will engage in a 16-week supervised exercise program. Studies indicate that regular, supervised exercise benefits quality of life more than not exercising at all. Exercise programs have successfully prevented weight gain, lowered blood pressure, and enhanced physical abilities in cancer patients. Additionally, high-intensity interval training (HIIT) has helped slow cancer cell growth and reduce prostate-specific antigen (PSA) levels, indicators of prostate cancer. These findings suggest that a supervised exercise program may offer significant benefits for those receiving treatment for advanced prostate cancer.12367
Who Is on the Research Team?
Christina M Dieli-Conwright, PhD
Principal Investigator
Dana-Farber Cancer Institute
Are You a Good Fit for This Trial?
The FIERCE Trial is for English-speaking men over 18 with metastatic prostate cancer who are pre-frail or frail and on ADT. They must be willing to travel to Dana-Farber Cancer Institute, have physician clearance for exercise, and not already doing much structured exercise.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants partake in a 16-week supervised exercise program or continue with normal activities
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Supervised Circuit Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
Prostate Cancer Foundation
Collaborator